These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21811911)

  • 21. An efficient approach to novel 17-5'-(1',2',4')-oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17α-hydroxylase/C₁₇,₂₀-lyase.
    Kovács D; Wölfling J; Szabó N; Szécsi M; Kovács I; Zupkó I; Frank E
    Eur J Med Chem; 2013; 70():649-60. PubMed ID: 24211641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists.
    Yoshino H; Sato H; Tachibana K; Shiraishi T; Nakamura M; Ohta M; Ishikura N; Nagamuta M; Onuma E; Nakagawa T; Arai S; Ahn KH; Jung KY; Kawata H
    Bioorg Med Chem; 2010 May; 18(9):3159-68. PubMed ID: 20381361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001): head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft model.
    Bruno RD; Vasaitis TS; Gediya LK; Purushottamachar P; Godbole AM; Ates-Alagoz Z; Brodie AM; Njar VC
    Steroids; 2011 Nov; 76(12):1268-79. PubMed ID: 21729712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.
    Ajduković JJ; Djurendić EA; Petri ET; Klisurić OR; Celić AS; Sakač MN; Jakimov DS; Gaši KM
    Bioorg Med Chem; 2013 Dec; 21(23):7257-66. PubMed ID: 24148837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor antagonists and anti-prostate cancer activities of some newly synthesized substituted fused pyrazolo-, triazolo- and thiazolo-pyrimidine derivatives.
    Bahashwan SA; Fayed AA; Ramadan MA; Amr Ael-G; Al-Harbi NO
    Int J Mol Sci; 2014 Nov; 15(11):21587-602. PubMed ID: 25421248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
    Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
    Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro antineoplastic evaluation of certain 16-(4-substituted benzylidene) derivatives of androst-5-ene.
    Dubey S; Piplani P; Jindal DP
    Chem Biodivers; 2004 Oct; 1(10):1529-36. PubMed ID: 17191796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel derivatives of diosgenin: design, synthesis and anti-tumor activity].
    Ding XY; He G; Jiang HP; Wan JF; Fan JZ
    Yao Xue Xue Bao; 2012 Apr; 47(4):479-85. PubMed ID: 22799030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel concepts in androgen receptor blockade.
    Hsieh AC; Ryan CJ
    Cancer J; 2008; 14(1):11-4. PubMed ID: 18303477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate.
    Kim W; Jones JO; Diamond M; Haqq C; Molina A; Small EJ; Ryan CJ
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):292-9. PubMed ID: 25047002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives.
    Gasi KM; Brenesel MDj; Djurendić EA; Sakac MN; Canadi JJ; Daljev JJ; Armbruster T; Andrić S; Sladić DM; Bozić TT; Novaković IT; Juranić ZD
    Steroids; 2007 Jan; 72(1):31-40. PubMed ID: 17118415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
    Goto T; Ohta K; Fujii S; Ohta S; Endo Y
    J Med Chem; 2010 Jul; 53(13):4917-26. PubMed ID: 20521823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical synthesis and biological activities of 16alpha-derivatives of 5alpha-androstane-3alpha,17beta-diol as antiandrogens.
    Roy J; Breton R; Martel C; Labrie F; Poirier D
    Bioorg Med Chem; 2007 Apr; 15(8):3003-18. PubMed ID: 17336533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.
    Lin L; Shi Q; Nyarko AK; Bastow KF; Wu CC; Su CY; Shih CC; Lee KH
    J Med Chem; 2006 Jun; 49(13):3963-72. PubMed ID: 16789753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer.
    Pinto-Bazurco Mendieta MA; Negri M; Jagusch C; Müller-Vieira U; Lauterbach T; Hartmann RW
    J Med Chem; 2008 Aug; 51(16):5009-18. PubMed ID: 18672868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists.
    Guo C; Linton A; Kephart S; Ornelas M; Pairish M; Gonzalez J; Greasley S; Nagata A; Burke BJ; Edwards M; Hosea N; Kang P; Hu W; Engebretsen J; Briere D; Shi M; Gukasyan H; Richardson P; Dack K; Underwood T; Johnson P; Morell A; Felstead R; Kuruma H; Matsimoto H; Zoubeidi A; Gleave M; Los G; Fanjul AN
    J Med Chem; 2011 Nov; 54(21):7693-704. PubMed ID: 21936524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel anticancer agents through opening of spiroacetal ring of diosgenin.
    Hamid AA; Hasanain M; Singh A; Bhukya B; Omprakash ; Vasudev PG; Sarkar J; Chanda D; Khan F; Aiyelaagbe OO; Negi AS
    Steroids; 2014 Sep; 87():108-18. PubMed ID: 24929045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.